[HTML][HTML] Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies–a review

AM Al-Abd, AJ Alamoudi, AB Abdel-Naim… - Journal of advanced …, 2017 - Elsevier
Recent strategies for the treatment of cancer, other than just tumor cell killing have been
under intensive development, such as anti-angiogenic therapeutic approach. Angiogenesis …

Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect

Z Liu, Y Zhang, N Shen, J Sun, Z Tang… - Advanced Drug Delivery …, 2022 - Elsevier
Nanomedicine greatly improves the efficiency in the delivery of antitumor drugs into the
tumor, but insufficient tumoral penetration impairs the therapeutic efficacy of most …

The use of African medicinal plants in cancer management

G Gaobotse, S Venkataraman, PD Brown… - Frontiers in …, 2023 - frontiersin.org
Cancer is the third leading cause of premature death in sub-Saharan Africa. Cervical cancer
has the highest number of incidences in sub-Saharan Africa due to high HIV prevalence …

Vascular disrupting agents in cancer therapy

R Smolarczyk, J Czapla, M Jarosz-Biej… - European journal of …, 2021 - Elsevier
Tumor blood vessel formation is a key process for tumor expansion. Tumor vessels are
abnormal and differ from normal vessels in architecture and components. Besides oxygen …

[HTML][HTML] Beyond the paclitaxel and vinca alkaloids: Next generation of plant-derived microtubule-targeting agents with potential anticancer activity

D Zhang, A Kanakkanthara - Cancers, 2020 - mdpi.com
Plants are an important source of chemically diverse natural products that target
microtubules, one of the most successful targets in cancer therapy. Colchicine, paclitaxel …

Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent …

YX Sun, J Song, LJ Kong, BB Sha, XY Tian… - European Journal of …, 2022 - Elsevier
As the continuation of our work on the development of tubulin inhibitors with potential
anticancer activities, novel bis-substituted aromatic amide dithiocarbamate derivatives were …

Harnessing plant biodiversity for the discovery of novel anticancer drugs targeting microtubules

S **e, J Zhou - Frontiers in plant science, 2017 - frontiersin.org
The microtubule cytoskeleton plays a critical role in a wide range of cellular activities and
has been shown to be a highly effective target for the treatment of human malignancies …

Recent advances in combretastatin A-4 codrugs for cancer therapy

K Guo, X Ma, J Li, C Zhang, L Wu - European Journal of Medicinal …, 2022 - Elsevier
CA4 is a potent microtubule polymerization inhibitor and vascular disrupting agent.
However, the in vivo efficiency of CA4 is limited owing to its poor pharmacokinetics resulting …

Recent advances of antitumor leading compound Erianin: Mechanisms of action and structural modification

L Ma, M Li, Y Zhang, K Liu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Erianin, a bioactive compound extracted from Dendrobium, a traditional Chinese medicine,
exhibits remarkable anti-cancer properties through diverse molecular mechanisms and has …

Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics

JH Gill, KL Rockley, C De Santis… - Pharmacology & …, 2019 - Elsevier
Destruction of the established tumour vasculature by a class of compound termed Vascular
Disrupting Agents (VDAs) is showing considerable promise as a viable approach for the …